Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Trump's Executive Order Proposes Separating Childhood Vaccines Amid Expert Concerns

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Politics

Trump's Executive Order Proposes Separating Childhood Vaccines Amid Expert Concerns

Analysed 13 Aug 2026·2 sources analysed·United States·Politics
Trump's Executive Order Proposes Separating Childhood Vaccines Amid Expert ConcernsPreviousNext

President Donald Trump's executive order proposes separating combination childhood vaccines like MMR into individual shots and increasing spacing between immunizations. Public health experts criticize the plan, citing lack of scientific support and concerns over increased costs, logistical challenges, and risks of missed doses. Implementing the changes would require drugmakers to restart production of individual vaccines not marketed separately in decades, involving costly studies and new manufacturing. States maintain authority over school vaccination mandates, which may limit the order's impact.

Sentiment
32%
TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is negative (32/100). Lens Score 64/100.

Outlets measured: economictimes, indiatoday. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 13 Aug 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Negative (32/100)

Sentiment was consistent across outlets (28–35/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

indiatoday broke this story on 13 Aug, 11:10 am. Other outlets followed.

13 Aug, 11:10 am2 sources · 3 h13 Aug, 01:55 pm
  1. 1
AI analysis by the TBN Bias Engine · beat methodology byPrajakta Kale· Political Analyst· editorial standards byOjas Kale
← Previous
Russia Rejects Black Sea Ceasefire Proposal Amid Rising Attacks on Shipping
Next →
Punjab's Mukh Mantri Sehat Yojana Provides Over Six Lakh Treatments with Rs 10 Lakh Coverage
indiatoday13 Aug, 11:10 am
US experts slam Trump's plan to split MMR into separate childhood shots
  • 2
    economictimes13 Aug, 01:55 pm
    Trump's vaccine overhaul could bring more shots, higher costs for US families
  • Who's involved

    Institutions and figures named across source coverage.

    Government
    Office of the President of the United StatesUnited States Department of Health and Human ServicesFood and Drug AdministrationUnited States Government
    Corporate
    Merck & Co. IncorporatedGlaxoSmithKline plc
    Political
    Republican Party

    Story context

    Category
    Politics
    Location
    United States
    Sources analysed
    2
    Last analysed
    13 Aug 2026
    Key entities
    MeaslesVaccineFood and Drug AdministrationMumpsRubellaMMR vaccinePublic healthExecutive order (United States)Merck & Co.Pharmaceutical industryDonald TrumpImmune response